These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7492437)

  • 41. Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection.
    Bariou C; Genetet N; Ruffault A; Michelet C; Cartier F; Genetet B
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1301-12. PubMed ID: 9339847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia.
    MacDonell KB; Chmiel JS; Poggensee L; Wu S; Phair JP
    Am J Med; 1990 Dec; 89(6):706-12. PubMed ID: 1979205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of death.
    Aladdin H; Ullum H; Lepri AC; Leffers H; Katzenstein T; Gerstoft J; Gjedde SB; Phillips AN; Skinhøj P; Pedersen BK
    Scand J Immunol; 1999 Aug; 50(2):223-7. PubMed ID: 10447929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consistent subtype-specific anti-HIV type 1 T lymphocyte responses in Indian subjects recently infected with HIV type 1.
    Thakar MR; Patke D; Lakhashe SK; Bhonge L; Kulkarni SV; Tripathy SP; Gupte N; Brookmeyer R; Quinn TC; Paranjape RS; Bollinger RC
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1389-93. PubMed ID: 12487810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians.
    Tsegaye A; Ran L; Wolday D; Petros B; Nanlohy NM; Meles H; Girma M; Hailu E; Borghans J; Miedema F; van Baarle D
    AIDS; 2007 Jan; 21(3):369-72. PubMed ID: 17255746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
    Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
    J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
    Kundu SK; Katzenstein D; Moses LE; Merigan TC
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11204-8. PubMed ID: 1360665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    Koup RA; Pikora CA; Luzuriaga K; Brettler DB; Day ES; Mazzara GP; Sullivan JL
    J Exp Med; 1991 Dec; 174(6):1593-600. PubMed ID: 1744586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients.
    Kinney JS; Conway JH; Hilgartner MW; Clayman B; Mayur K; Yolken RH; Viscidi RP
    Am J Hematol; 1991 Jan; 36(1):35-41. PubMed ID: 1984680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
    Nair MP; Schwartz SA
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo.
    Greenough TC; Brettler DB; Somasundaran M; Panicali DL; Sullivan JL
    J Infect Dis; 1997 Jul; 176(1):118-25. PubMed ID: 9207357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens.
    Friedman RS; Frankel FR; Xu Z; Lieberman J
    J Virol; 2000 Nov; 74(21):9987-93. PubMed ID: 11024127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection.
    McAdam S; Kaleebu P; Krausa P; Goulder P; French N; Collin B; Blanchard T; Whitworth J; McMichael A; Gotch F
    AIDS; 1998 Apr; 12(6):571-9. PubMed ID: 9583596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination.
    Balamurugan A; Lewis MJ; Kitchen CM; Robertson MN; Shiver JW; Daar ES; Pitt J; Ali A; Ng HL; Currier JS; Yang OO
    J Virol; 2008 Mar; 82(6):2784-91. PubMed ID: 18199650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression.
    Lubaki NM; Ray SC; Dhruva B; Quinn TC; Siliciano RF; Bollinger RC
    J Infect Dis; 1997 Jun; 175(6):1360-7. PubMed ID: 9180175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection.
    Nemes E; Bertoncelli L; Lugli E; Pinti M; Nasi M; Manzini L; Manzini S; Prati F; Borghi V; Cossarizza A; Mussini C
    AIDS; 2010 Apr; 24(7):947-57. PubMed ID: 20179574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The anti-idiotypic antibody 1F7 selectively inhibits cytotoxic T cells activated in HIV-1 infection.
    Grant M; Smaill F; Muller S; Kohler H; Rosenthal K
    Immunol Cell Biol; 2000 Feb; 78(1):20-7. PubMed ID: 10651925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.